Influenza Vaccination Appropriateness: Insights from the Local Health Unit of Catania During the 2023/2024 and 2024/2025 Seasons.

IF 5.2 3区 医学 Q1 IMMUNOLOGY
Vaccines Pub Date : 2025-08-30 DOI:10.3390/vaccines13090925
Francesco Leonforte, Claudio Fiorilla, Gabriele Giorgianni, Vito Nicosia, Fabio Contarino, Cristina Genovese, Giovanni Genovese, Giustino Morlino, Martina Chimienti, Antonio Mistretta
{"title":"Influenza Vaccination Appropriateness: Insights from the Local Health Unit of Catania During the 2023/2024 and 2024/2025 Seasons.","authors":"Francesco Leonforte, Claudio Fiorilla, Gabriele Giorgianni, Vito Nicosia, Fabio Contarino, Cristina Genovese, Giovanni Genovese, Giustino Morlino, Martina Chimienti, Antonio Mistretta","doi":"10.3390/vaccines13090925","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives</b>: Influenza poses a substantial global public health challenge, disproportionately affecting vulnerable populations. Vaccination is the most effective preventive measure, and recent strategies in Italy emphasize the principle of \"appropriateness\"-the alignment of specific vaccine formulations (e.g., adjuvanted or high-dose) with targeted risk groups to optimize protection. Nevertheless, challenges persist in ensuring the consistent administration of the most suitable vaccine, particularly among high-risk individuals who would benefit most. <b>Methods</b>: A retrospective descriptive study was conducted using data from the 2023-2024 and 2024-2025 influenza vaccination campaigns of the Local Health Authority of Catania. Vaccination data were analyzed by age group and vaccine type, based on national immunization guidelines. Population categories included individuals ≥ 65 years, adults 60-64 years, adults 18-59 years (with/without chronic conditions), children, and pregnant/postpartum women. Vaccine types analyzed were aQIV, QIV-HD, QIV-SD, QIVcc, and LAIV. Descriptive statistics were used, and Relative Risk (RR) with 95% Confidence Intervals (CI) was calculated using the 60-64 age group as a reference. Analyses were performed with Stata 18.0. <b>Results</b>: In 2023-2024, 78.8% of individuals ≥ 65 received recommended vaccines, compared to 100% in the 60-64 group (RR = 0.23; 95% CI: 0.225-0.231). Adults 18-59, children, and pregnant/postpartum women showed ≥99% adherence. In 2024-2025, appropriateness in the ≥65 group improved to 96.1% (RR = 0.12; 95% CI: 0.118-0.128). All other groups maintained high adherence (≥99%), except for 6.2% of children aged 6 months-2 years who inappropriately received LAIV. <b>Conclusions</b>: Despite dramatically improved vaccination appropriateness in the elderly, a persistent and critical safety issue--inappropriate administration LAIV use in 6.2% of young children-highlights the need for targeted interventions to ensure complete patient safety.</p>","PeriodicalId":23634,"journal":{"name":"Vaccines","volume":"13 9","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474316/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/vaccines13090925","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: Influenza poses a substantial global public health challenge, disproportionately affecting vulnerable populations. Vaccination is the most effective preventive measure, and recent strategies in Italy emphasize the principle of "appropriateness"-the alignment of specific vaccine formulations (e.g., adjuvanted or high-dose) with targeted risk groups to optimize protection. Nevertheless, challenges persist in ensuring the consistent administration of the most suitable vaccine, particularly among high-risk individuals who would benefit most. Methods: A retrospective descriptive study was conducted using data from the 2023-2024 and 2024-2025 influenza vaccination campaigns of the Local Health Authority of Catania. Vaccination data were analyzed by age group and vaccine type, based on national immunization guidelines. Population categories included individuals ≥ 65 years, adults 60-64 years, adults 18-59 years (with/without chronic conditions), children, and pregnant/postpartum women. Vaccine types analyzed were aQIV, QIV-HD, QIV-SD, QIVcc, and LAIV. Descriptive statistics were used, and Relative Risk (RR) with 95% Confidence Intervals (CI) was calculated using the 60-64 age group as a reference. Analyses were performed with Stata 18.0. Results: In 2023-2024, 78.8% of individuals ≥ 65 received recommended vaccines, compared to 100% in the 60-64 group (RR = 0.23; 95% CI: 0.225-0.231). Adults 18-59, children, and pregnant/postpartum women showed ≥99% adherence. In 2024-2025, appropriateness in the ≥65 group improved to 96.1% (RR = 0.12; 95% CI: 0.118-0.128). All other groups maintained high adherence (≥99%), except for 6.2% of children aged 6 months-2 years who inappropriately received LAIV. Conclusions: Despite dramatically improved vaccination appropriateness in the elderly, a persistent and critical safety issue--inappropriate administration LAIV use in 6.2% of young children-highlights the need for targeted interventions to ensure complete patient safety.

Abstract Image

Abstract Image

流感疫苗接种的适当性:来自卡塔尼亚当地卫生单位在2023/2024和2024/2025季节的见解
背景/目标:流感对全球公共卫生构成重大挑战,对脆弱人群的影响尤为严重。疫苗接种是最有效的预防措施,意大利最近的战略强调“适当性”原则——将特定疫苗配方(例如,佐剂或高剂量)与目标风险群体保持一致,以优化保护。然而,在确保始终如一地接种最合适的疫苗方面,特别是在受益最大的高危人群中,仍然存在挑战。方法:对卡塔尼亚地方卫生局2023-2024年和2024-2025年流感疫苗接种活动的数据进行回顾性描述性研究。根据国家免疫指南,按年龄组和疫苗类型分析疫苗接种数据。人群类别包括≥65岁的个体、60-64岁的成年人、18-59岁的成年人(有/无慢性疾病)、儿童和孕妇/产后妇女。分析的疫苗类型为aQIV、QIV-HD、QIV-SD、QIVcc和LAIV。采用描述性统计,以60-64岁年龄组为参照,计算具有95%置信区间(CI)的相对危险度(RR)。采用Stata 18.0进行分析。结果:2023-2024年,78.8%≥65岁的个体接种了推荐疫苗,而60-64岁组为100% (RR = 0.23; 95% CI: 0.225-0.231)。18-59岁的成年人、儿童和孕妇/产后妇女依从性≥99%。2024-2025年,≥65岁组的适宜性提高到96.1% (RR = 0.12; 95% CI: 0.118-0.128)。除6.2%的6个月-2岁儿童不适当接受LAIV外,所有其他组均保持高依从性(≥99%)。结论:尽管老年人接种疫苗的适宜性显著提高,但持续存在的严重安全问题——6.2%的幼儿接种LAIV不当——凸显了有针对性干预措施的必要性,以确保患者的完全安全。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vaccines
Vaccines Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
8.90
自引率
16.70%
发文量
1853
审稿时长
18.06 days
期刊介绍: Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信